✦ LIBER ✦

Potential Economic Impact of Glycoprotein IIb-IIIa Inhibitors in Improving Outcomes of Patients with Acute Ischemic Coronary Syndromes

✍ Scribed by Newell E McElwee; PharmD; MSPH; Eric R Johnson; PhD

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Emerging Treatment of Acute Coronary Syn

✍ Matthew T. Roe; David J. Moliterno 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 159 KB

Overview of clinical trials of glycoprot

✍ Robert A. Harrington 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 207 KB

Platelet glycoprotein IIb/IIIa inhibitor

✍ M. Roffi; D.P. Chew; D. Mukherjee 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Influence of concurrent renal dysfunctio

✍ R.V. Freeman; R.H. Mehta; W. Al Badr; J.V. Cooper; E. Kline-Rogers; K.A. Eagle 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 36 KB

The Evolving Role of Glycoprotein IIb/II

✍ PIERLUIGI TRICOCI; ERIC D. PETERSON 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB

Evaluating the benefits of glycoprotein

✍ Monvadi B Srichai; Wael A Jaber; David L Prior; Steven P Marso; Penny L Houghtal 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 135 KB